Phase 2Recruiting
Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS
Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in Uterine Leiomyosarcoma
- Sponsor
- M.D. Anderson Cancer Center (Academic or other)
- Enrolment
- 48 planned
- Conditions
- Uterine Leiomyosarcoma
- Interventions
- Trabectedin; Doxorubicin Hydrochloride
- Ages
- adults, older adults
- Registry
- NCT07076186
From the registry
To find out if receiving standard chemotherapy (doxorubicin and trabectedin) can extend the cancer-free survival of patients with Stage 1b/2 uterine leiomyosarcoma who had surgery that fully removed the tumor.
Primary outcomes
- Safety and Adverse Events (AEs)